...
首页> 外文期刊>BMC Cancer >Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
【24h】

Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer

机译:胃癌组织中HIF-1α,p53和VEGF表达与术前血清VEGF水平的临床病理意义

获取原文
           

摘要

Background Hypoxia influences tumor growth by inducing angiogenesis and genetic alterations. Hypoxia-inducible factor 1α (HIF-1α), p53, and vascular endothelial growth factor (VEGF) are all important factors in the mechanisms inherent to tumor progression. In this work, we have investigated the clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF (sVEGF) level in gastric cancer. We immunohistochemically assessed the HIF-1α, p53, and VEGF expression patterns in 114 specimens of gastric cancer. Additionally, we determined the levels of preoperative serum VEGF (sVEGF). Results The positive rates of p53 and HIF-1α (diffuse, deep, intravascular pattern) were 38.6% and 15.8%, respectively. The VEGF overexpression rate was 57.9%. p53 and HIF-1α were correlated positively with the depth of invasion ( P = 0.015, P = 0.001, respectively). Preoperative sVEGF and p53 levels were correlated significantly with lymph node involvement ( P = 0.010, P = 0.040, respectively). VEGF overexpression was more frequently observed in the old age group (≥ 60 years old) and the intestinal type ( P = 0.013, P = 0.014, respectively). However, correlations between preoperative sVEGF level and tissue HIF-1α, VEGF, and p53 were not observed. The median follow-up duration after operation was 24.5 months. HIF-1α was observed to be a poor prognostic factor of disease recurrence or progression ( P = 0.002). Conclusion p53, HIF-1α and preoperative sVEGF might be markers of depth of invasion or lymph node involvement. HIF-1α expression was a poor prognostic factor of disease recurrence or progression in patients with gastric cancers.
机译:背景低氧通过诱导血管生成和遗传改变影响肿瘤的生长。缺氧诱导因子1α(HIF-1α),p53和血管内皮生长因子(VEGF)都是肿瘤进展固有机制中的重要因素。在这项工作中,我们调查了胃癌中HIF-1α,p53和VEGF表达以及术前血清VEGF(sVEGF)水平的临床病理意义。我们通过免疫组化方法评估了114例胃癌标本中的HIF-1α,p53和VEGF表达模式。此外,我们确定了术前血清VEGF(sVEGF)的水平。结果p53和HIF-1α(弥漫性,深部,血管内型)的阳性率分别为38.6%和15.8%。 VEGF过表达率为57.9%。 p53和HIF-1α与浸润深度呈正相关(分别为P = 0.015,P = 0.001)。术前sVEGF和p53水平与淋巴结受累有显着相关性(分别为P = 0.010,P = 0.040)。在老年组(≥60岁)和肠道类型(分别为P = 0.013,P = 0.014)中,VEGF过表达更为常见。但是,未观察到术前sVEGF水平与组织HIF-1α,VEGF和p53之间的相关性。术后中位随访时间为24.5个月。观察到HIF-1α是疾病复发或进展的不良预后因素(P = 0.002)。结论p53,HIF-1α和术前sVEGF可能是浸润深度或淋巴结受累的标志。 HIF-1α表达是胃癌患者疾病复发或进展的不良预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号